Together, our findings indicated that PG5-AS1 is significantly down-regulated in NSCLC and that low expression of PGM5-AS1 is significantly associated with the worse overall survival of NSCLC patients. The gene discussed is PGM5; the disease is non-small cell lung carcinoma.